INVO Bioscience, Inc. enters $5M Series A Preferred Stock purchase agreement with NAYA Biosciences

INVO Fertility, Inc.

NAYA to purchase up to 1,000,000 shares of Series A Preferred Stock at $5.00/share, total up to $5,000,000.
First tranche of $500,000 closed on January 4, 2024 for 100,000 shares.
Remaining tranches: $500,000 each by Jan 19, Feb 2, Feb 16, 2024, plus additional amount for merger.
Proceeds to support INVO's fertility business, including catch-up on past due payables.
Agreement is in connection with previously announced merger between INVO and NAYA.

item 1.01 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INVO Fertility, Inc. entered into SPA with NAYA Biosciences, Inc. valued at $5.00 per share (effective 2023-12-29).

Action: entry
Agreement: equity purchase
Counterparty: NAYA Biosciences, Inc.
Value: $5.00 per share
Effective: 2023-12-29

Exact text from the filing

On December 29, 2023, INVO Bioscience, Inc., a Nevada corporation (the “ Company ”) entered into securities purchase agreement (the “ SPA ”) with NAYA Biosciences, Inc., a Delaware corporation (“ NAYA ”) for the purchase of 1,000,000 shares of the Company’s Series A Preferred Stock at a purchase price of $5.00 per share.

View on SEC.gov

268 material agreements filed in the last 30 days. Browse all material agreements →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-001940

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.